Why the study?
What are the bivalirudin dosing requirements for anticoagulation in pediatric patients on mechanical circulatory support?
What are the bivalirudin dosing requirements for anticoagulation in pediatric patients on mechanical circulatory support?
Bivalirudin dosing in pediatric patients on ECMO and VAD is consistent with prior reports, though VAD patients may require higher doses.
Answers are grounded in this paper and cite their sources.
Supports current dosing in pediatric ECMO/VAD; confirms prior reports but leaves open randomized validation.
Bivalirudin dosing in ECMO and VAD patients is consistent with dosing seen in previous reports but may be higher in VAD patients. Comparative studies between heparin and bivalirudin are necessary to compare cost-effective outcomes for pediatric patients.
No takes yet. Share an insight, caveat, or question.
Campbell et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: